Maximilian Lennartz, Verena Sofia Ullmann, Natalia Gorbokon, Ria Uhlig, Sebastian Dwertmann Rico, Simon Kind, Viktor Reiswich, Florian Viehweger, Martina Kluth, Claudia Hube-Magg, Christian Bernreuther, Franziska Büscheck, Devita Putri, Till S Clauditz, Christoph Fraune, Andrea Hinsch, Frank Jacobsen, Till Krech, Patrick Lebock, Stefan Steurer, Eike Burandt, Sarah Minner, Andreas H Marx, Ronald Simon, Guido Sauter, Anne Menz
BACKGROUND: Cytokeratin 13 (CK13) is a type I acidic low molecular weight cytokeratin which is mainly expressed in urothelium and in squamous epithelium of various sites of origin. Loss of CK13 has been implicated in development and progression of squamous epithelial neoplasms. RESULTS: To comprehensively determine CK13 expression in normal and neoplastic tissues, a tissue microarray containing 10,439 samples from 131 different tumor types and subtypes as well as 608 samples of 76 different normal tissue types was analyzed by immunohistochemistry...
October 21, 2022: APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica